Abstract |
Cyclic hematopoiesis in gray collie dogs can be cured by lithium treatment. We examined the mechanism of lithium's effect by developing an assay for the canine equivalent of GM-CSF (called GM-CSA). Phytohemagglutinin (PHA)-stimulated canine blood mononuclear cells produce GM-CSA in a dose-dependent manner; this GM-CSA stimulates more neutrophil-containing colonies than does endotoxin-treated dog serum. Production of GM-CSA by PHA-stimulated normal dog cells was not altered by lithium. However, cells from gray collies during their neutrophilic period increased their GM-CSA when lithium (2 mEq/L) was added to low doses of PHA, whereas neutropenic gray collie cells did not. These data suggest that lithium could modulate cyclic hematopoiesis by increasing intramedullary GM-CSA at the time when marrow neutrophilic progenitor cells are at their nadir.
|
Authors | W P Hammond, E R Rodger, D C Dale |
Journal | Blood
(Blood)
Vol. 69
Issue 1
Pg. 117-23
(Jan 1987)
ISSN: 0006-4971 [Print] United States |
PMID | 3491636
(Publication Type: Journal Article, Research Support, U.S. Gov't, P.H.S.)
|
Chemical References |
- Cyclosporins
- Interleukin-3
- Phytohemagglutinins
- Lithium
|
Topics |
- Animals
- Cells, Cultured
- Cyclosporins
(pharmacology)
- Dog Diseases
(drug therapy)
- Dogs
- Female
- Hematologic Diseases
(drug therapy, veterinary)
- Hematopoiesis
(drug effects)
- Interleukin-3
(biosynthesis)
- Lithium
(pharmacology, therapeutic use)
- Macrophages
(physiology)
- Male
- Neutrophils
(physiology)
- Phytohemagglutinins
(pharmacology)
|